Mytsi L. Coker

Procter & Gamble (United States) — United States

Medicine · Health Sciences

16h-index3.2kcitations19works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiac Fibrosis and Remodeling(15), Protease and Inhibitor Mechanisms(14), Peptidase Inhibition and Analysis(14), Cardiac Structural Anomalies and Repair(4), Signaling Pathways in Disease(3)

Publications19 total

Selective Matrix Metalloproteinase Inhibition With Developing Heart Failure
Circulation Research·2003· 100 citedOpen Access
Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure
Journal of Cardiac Failure·2002· 107 cited
Left Ventricular Remodeling in Transgenic Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor
Circulation·2001· 374 citedOpen Access
Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation
American Journal of Physiology-Heart and Circulatory Physiology·2001· 102 cited
Matrix Metalloproteinase Inhibition Attenuates Left Ventricular Remodeling and Dysfunction in a Rat Model of Progressive Heart Failure
Circulation·2001· 301 cited
A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart Failure
Circulation·2000· 475 cited
Effects of Gene Deletion of the Tissue Inhibitor of the Matrix Metalloproteinase-type 1 (TIMP-1) on Left Ventricular Geometry and Function in Mice
Journal of Molecular and Cellular Cardiology·2000· 127 cited
Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control
American Journal of Physiology-Heart and Circulatory Physiology·2000· 128 cited
A novel MMP stimulatory protein, EMMPRIN, is expressed in human myocardium and is upregulated in dilated cardiomyopathy
Journal of Cardiac Failure·1999
Identification of novel matrix metalloproteinase inducers and activators in normal adult human left ventricular myocytes
Journal of Cardiac Failure·1999
Matrix Metalloproteinase Inhibition During the Development of Congestive Heart Failure
Circulation Research·1999· 324 citedOpen Access
Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations
American Journal of Physiology-Heart and Circulatory Physiology·1999· 119 cited
Defects in Matrix Metalloproteinase Inhibitory Stoichiometry and Selective MMP Induction in Patients with Nonischemic or Ischemic Dilated Cardiomyopathy
Annals of the New York Academy of Sciences·1999· 19 cited
Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy
Journal of Cardiac Failure·1998· 24 cited
Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations
Journal of Cardiac Failure·1998· 22 cited
Increased Matrix Metalloproteinase Activity and Selective Upregulation in LV Myocardium From Patients With End-Stage Dilated Cardiomyopathy
Circulation·1998· 444 cited
Myocardial Extracellular Matrix Remodeling with the Development of Pacing Induced Congestive Heart Failure
Cardiovascular Pathology·1998· 3 cited
Myocardial matrix metalloproteinase activity and abundance with congestive heart failure
American Journal of Physiology-Heart and Circulatory Physiology·1998· 128 cited
Time-Dependent Changes in Matrix Metalloproteinase Activity and Expression During the Progression of Congestive Heart Failure
Circulation Research·1998· 370 citedOpen Access

Frequent Co-authors

Francis G. Spinale(18), James L. Zellner(6), Chadwick V. Thomas(6), Arthur J. Crumbley(4), Lena J. Heung(3), Brian R. Bond(3), Himali R. Gunasinghe(3), Takuma Etoh(3), Rupak Mukherjee(3), Michael R. Zile(3), John R. Handy(2), Douglas L. Mann(2), Hussein Hallak(2), Mark J. Clair(2), Janet T. Peterson(2), Zorina S. Galis(2), Shintaro Nemoto(2), Melissa A. Doscher(2), Aron T. Goldberg(1), Natarajan Sivasubramanian(1)